Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06191289 · ClinicalTrials.gov registry record · Phase 2
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
A Phase 2 study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT06191289 is a Phase 2 study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 11 participants.
The verdict
NCT06191289, a Phase 2 study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
This within-person, crossover, 2-condition, placebo-controlled study compares the impact of two perimenstrual conditions on severity of suicidal symptoms in females with past-month suicidality but minimal risk of imminent suicide attempt. The two conditions are (1) perimenstrual administration of estradiol and (2) natural perimenstrual withdrawal from estradiol during placebo.
Interventions
- OTHER Placebo
- DRUG Transdermal Estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-03-16 |
| Est. Completion | 2024-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06191289
The ClinicalTrials.gov registry entry for NCT06191289 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06191289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06191289 about?
NCT06191289 is a clinical study titled "Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality". This within-person, crossover, 2-condition, placebo-controlled study compares the impact of two perimenstrual conditions on severity of suicidal symptoms in females with past-month suicidality but minimal risk of imminent suicide attempt. The two conditions are (1) perimenstrual administration of es...
What is the current status of trial NCT06191289?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2024-03-16. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT06191289?
The interventions under investigation include: Placebo (OTHER), Transdermal Estradiol (DRUG).
Who is sponsoring clinical trial NCT06191289?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.